Testosterone and dehydroepiandrosterone sulphate levels and IVF/ICSI results

References

• Fratharelli J L, Peterson E H. Effect of androgen levels on IVF cycles. Fertil steril 2004; 81: 1713–1714
   Google Scholar
• Casson P R, Lindsay M S, Pisarska M D, Carsen S A, Buster J A. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum reprod 2000; 15: 2129–2132
   PubMed Web of Science ®Google Scholar
• Weil S, Vendola K, Zhoe J, Bondy C A. Androgen and follicle stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1998; 84: 2951–2956
   Google Scholar
• Colakoglu M. The effect of DHEAS, prolactin and testosterone hormones in female fertility and hirsutim. Clin Exp Obstet Gynecol 1986; 13: 34–40
   Google Scholar
• Labrie F, Luu-The V, Labrie C, Belanger A, Simard J, Lin S X, Pelletier G. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003; 24: 152–182
   PubMed Web of Science ®Google Scholar
• Andersen C Y, Lossl K. Increased intrafollicular androgen levels affect human granulose cell secretion of anti-mullerian hormone and inhibin-B. Fertil Steril 2008; 89: 1760–1765
   PubMed Web of Science ®Google Scholar
• Bonser J, Walker J, Purohit A, Reed M J, Potter B V, Willis D S, Franks S, Mason H D. Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production. J Endocrinol 2000; 167: 465–471
   PubMed Web of Science ®Google Scholar
• Balash J, Fabregues F, Penarrubia J, Carmona F, Casamitjana R, Creus M, Manau D, Casals G, Vanrell J A. Pretreatment with transdermal testosterone may improve ovarian response to gonadotropins in poor responder IVF patients with normal basal concentration of FSH. Hum Reprod 2006; 21: 1884–1893
   Google Scholar
• Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intraovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 2004; 10: 107–117
   PubMed Web of Science ®Google Scholar
• Pache T D, Fauser B C. Polycystic ovaries in female to male transsexuals. Clin Endocrinol 1993; 39: 702–703
   PubMed Web of Science ®Google Scholar
• Webber L J, Stubbs S, Stark J, Trew G H, Margara R, Hardy K, Franks S. Formation and early development of follicles in the polycystic ovary. Lancet 2003; 362: 1017–1021
   PubMed Web of Science ®Google Scholar
• Jonard S, Robert Y, Cortet- Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries is it worth counting the follicles. Hum Reprod 2003; 18: 598–603
   PubMed Web of Science ®Google Scholar
• Massin N, Cedrin-Durnerin I, Galey-Fontaine J, Coussieu C, Bry-Gauillard H, Hughes J N. Is androgen application beneficial for low responders. Hum Reprod 2004; 19: 20–21
   Google Scholar
• Kjotrod S B, Sunde A, Düring V, Carlsen S M. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome. Fertil steril, In Press, corrected proof, Available online 4 March 2008
   Google Scholar
• Haning R V, Flood C A, Hackett R J, Loughlin J S, McClure N, Longscope C. Metabolic clearance rate of dehydroepiandrosterone sulphate, its metabolism to testosterone, and its intrafolllicular metabolism to dehydrotestosterone, androsterone, testosterone, and dihydrotestosterone in vivo. J Clin Endocrinol Metab 1991; 72: 1088–1095
   PubMed Web of Science ®Google Scholar
• Labrie F, Luu-The V, Lin S X, Simard J, Labrie C, El-Alfy M, Pelletier G, Belanger A. Intracrinology: the role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 2000; 25: 1–16
   PubMed Web of Science ®Google Scholar
• Shimokata H, Muller D C, Fleg J L, Sorkin J, Ziemba A W, Andres R. Age as an independent determinant of glucose tolerance. Diabetes 1991; 40: 44–51
   PubMed Web of Science ®Google Scholar
• Kreisberg R A. Aging, glucose metabolism, and diabetes: current concepts. Geriatrics 1987; 42: 67–72
   PubMed Web of Science ®Google Scholar
• Moran C, Knochenhauer E, Boots L R, Azziz R. Adrenal androgen excess in hyperandrogenism: relation to age and body mass. Fertil Steril 1999; 71: 671–674
   PubMed Web of Science ®Google Scholar
• Wild R A, Umstot E S, Andersen R N, Ranney G B, Givens J R. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. Am J Obstet Gynecol 1983; 146: 602–606
   PubMed Web of Science ®Google Scholar
• Carmina E, Lobo R A. Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes. J Endocrinol Invest 2007; 30: 111–116
   PubMed Web of Science ®Google Scholar
• Rein M S, Jackson K V, Sable D B, Thomas P P, Hornstein M D. Dexamethasone during ovulation induction for IVF: a pilot study. Hum Reprod 1996; 11: 54–255
   Google Scholar
• Check J H, Nazeri A, Dietterich C. Comparison of androgen levels in conception cycle following controlled ovarian stimulation using the luteal phase gonadotropin- releasing hormone agonist protocol. Gynecol Endocrinol 1995; 9: 209–214
   PubMed Web of Science ®Google Scholar
• Garcia-Velasco J A, Moreno L, Pacheco A, Guillen A, Duque L, Requena A, Pellicer A. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil steril 2005; 84: 82–87
   PubMed Web of Science ®Google Scholar